Aseptic Processing / Packaging

Amgen: Do Electron Beams Impact Large Molecules?

As low-energy electron beams have gained acceptance in pharmaceutical aseptic processing and packaging, companies have done due diligence to research whether or not the technology could have any impact to the drug product. One such company is Amgen, which has studied potential irradiation of proteins during syringe tub sterilization. The findings so far: no significant impact, which is illustrated in the following poster, presented at the 2008 ISPE Annual Meeting in Boca Raton, Florida.

Free Subscriptions

Pharma Manufacturing Digital Edition

Access the entire print issue on-line and be notified each month via e-mail when your new issue is ready for you. Subscribe Today.

pharmamanufacturing.com E-Newsletters

A mix of feature articles and current new stories that are critical to staying up-to-date on the industry, delivered to your inbox. Choose from an assortment of different topics and frequencies. Subscribe Today.